Literature DB >> 20472705

Evaluation of Geese Theatre's Re-Connect program: addressing resettlement issues in prison.

Leigh Harkins1, Cecilia Pritchard, Donna Haskayne, Andy Watson, Anthony R Beech.   

Abstract

This study examined the impact of Geese Theatre's Re-Connect program on a sample of offenders who attended it. This program used theatre performance, experiential exercises, skills practice role-plays, and metaphors such as the masks to invite a group of offenders to consider and explore issues connected with their release and reconnecting with a life outside prison. Pre- and postprogram psychometric tests, behavior ratings, and interviews were completed to assess the effectiveness of the program. Significant changes were observed from pre- to posttreatment in terms of self-efficacy, motivation to change, and improved confidence in skills (i.e., social and friendship, occupational, family and intimacy, dealing with authority, alternatives to aggression or offending, and self-management and self-control skills). Improved behavior and engagement within the program was observed over the 3 days of the program. Interviews also revealed the positive impact the program had on the participants. This provides evidence supporting the short-term effectiveness of the Re-Connect program.

Entities:  

Mesh:

Year:  2010        PMID: 20472705     DOI: 10.1177/0306624X10370452

Source DB:  PubMed          Journal:  Int J Offender Ther Comp Criminol        ISSN: 0306-624X


  2 in total

1.  Integrative systematic review of psychodrama psychotherapy research: Trends and methodological implications.

Authors:  Hod Orkibi; Rinat Feniger-Schaal
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

2.  Initiating Change of People With Criminal Justice Involvement Through Participation in a Drama Project: An Exploratory Study.

Authors:  Adrian P Mundt; Pamela Marín; Caroline Gabrysch; Carolina Sepúlveda; Jacqueline Roumeau; Paul Heritage
Journal:  Front Psychiatry       Date:  2019-10-03       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.